In-vitro toxicology testing features cutting-edge laboratory techniques that assess the toxicity of substances outside living organisms. It is widely used in pharmaceutical, cosmetic, and chemical industries to evaluate the safety and potential risks of various compounds. The advantages include reduced reliance on animal testing, cost-effectiveness, faster results, and the ability to assess a wide range of compounds. In-vitro toxicology testing plays a vital role in ensuring product safety, driving innovation, and promoting ethical and sustainable practices in toxicity assessment.
According to Data Bridge Market Research, the Global In-Vitro Toxicology Testing Market is expected to reach USD 27,952.36 million by 2030. The market is expected to grow with a CAGR of 12.3% in the forecast period of 2023 to 2030.
“Growing awareness regarding in-vitro toxicology testing boosts the market’s growth”
The growing awareness regarding in-vitro toxicology testing is a key driver behind the growth of the in-vitro toxicology testing market. As the aging population increases, there is a heightened understanding of the need for specialized care and support for seniors. Families and caregivers are seeking professional assistance to ensure the well-being and comfort of elderly individuals. This rising demand for in-vitro toxicology testing services, including assisted living facilities, home care, and healthcare services tailored to seniors, propels the expansion of the in-vitro toxicology testing market.
What restraints the growth of the global in-vitro toxicology testing market?
“High costs associated with in-vitro testing methods and products restraints the market’s growth”
The in-vitro toxicology testing market faces growth constraints due to the high costs associated with in-vitro testing methods and products. Setting up and maintaining advanced laboratory facilities and procuring specialized testing equipment incur significant expenses. Additionally, the development and validation of in-vitro assays require extensive resources and expertise. These cost factors limit the adoption of in-vitro testing approaches, impacting market growth and hindering the widespread implementation of alternative toxicity testing methods in the pharmaceutical, cosmetics, and chemical industries.
Segmentation: Global In-Vitro Toxicology Testing Market
The global In-vitro toxicology testing market is segmented on the basis of product and service, toxicology end point and test, technology, method, industry, and distribution channel.
- On the basis of product and service, the in-vitro toxicology testing market is segmented into consumables, services, assays, equipments, and software.
- On the basis of toxicology end point and test, the in-vitro toxicology testing market is segmented into ADME (absorption, distribution, metabolism, and excretion) testing, cytotoxicity testing, genotoxicity testing, dermal toxicity testing, ocular toxicity testing, organ toxicity testing, skin irritation, corrosion, and sensitization testing, phototoxicity testing, and other toxicity endpoints and tests.
- On the basis of technology, the market is segmented into cell culture technologies, high-throughput technologies, molecular imaging, and OMICS technology.
- On the basis of method the market is segmented into cellular assays, biochemical assays, ex-vivo models, and in silico models.
- On the basis of industry the market is segmented into pharmaceutical & biopharmaceutical companies, diagnostics, food, chemicals, cosmetics, and household products.
- On the basis of distribution channel, the market is segmented into direct tender, retail sales, and others.
Regional Insights: North America is expected to dominate the Global In-Vitro Toxicology Testing Market
North America is expected to dominate the global in-vitro toxicology testing market during the forecast period owing to increasing demand for toxicology testing and continuous technological advancements. Within North America, the U.S. is expected to emerge as the dominant market, primarily due to the rising demand for in-vitro toxicology testing products in various industries. This growth trend reflects the region's recognition of the importance of safe and efficient toxicity assessment methods for product development and regulatory compliance.
Asia-Pacific is expected to grow during the forecast period, China is anticipated to be the dominant player due to the significant expansion of strategic initiatives by key market players. The country's strong economic growth, supportive government policies, and increasing investments in research and development have positioned it as a key hub for in-vitro toxicology testing, attracting major players and driving market growth in the region.
To know more about the study visit, https://www.databridgemarketresearch.com/de/reports/global-vitro-toxicology-testing-market
Recent Developments
- In June 2023, Lonza, a leading global manufacturing partner for the pharmaceutical, biotech, and nutraceutical industries, recently completed the acquisition of Synaffix B.V. (Synaffix), a biotechnology company specializing in advancing its clinical-stage technology platform for antibody-drug conjugates (ADCs) development. This strategic move is set to bolster Lonza's global footprint and enhance its capabilities in the ADC space, strengthening its position as a key player in the biopharmaceutical industry.
- In October 2022, Thermo Fisher Scientific Inc. has revealed plans to expand its laboratory operations in Highland Heights, Kentucky. This expansion is aimed at supporting biopharma customers in accelerating drug development and delivering life-changing medicines to patients. The current facility, equipped with central lab and biomarker operations, provides high-quality laboratory services to enhance the company's clinical diagnostics business and strengthen its global presence in the market across different regions.
The Prominent Key Players Operating in the Global In-Vitro Toxicology Testing Market Include:
- Thermo Fisher Scientific Inc. (U.S.)
- Labcorp Drug Development (U.S.)
- Merck KGaA (Germany)
- Charles River Laboratories (U.S.)
- Lonza (Switzerland)
- Bio-Rad Laboratories, Inc. (U.S.)
- Catalent, Inc. (U.S.)
- SGS Société Générale de Surveillance SA (Switzerland)
- QIAGEN (Germany)
- Intertek Group plc. (UK)
- Eurofins Scientific (Luxembourg)
- Promega Corporation (U.S.)
- Aragen Life Sciences Ltd. (India)
- Cyprotex Plc. (UK)
- Shanghai Medicilon Inc. (China)
- Creative Biolabs (U.S.)
- BioIVT (U.S.)
- AAT Bioquest, Inc. (U.S.)
- Gentronix (UK)
- IONTOX (U.S.)
- InSphero (U.S.)
- MB Research Laboratories (U.S.)
- Creative Bioarray (U.S.)
- Preferred Cell Systems (U.S.)
Above are the key players covered in the report, to know about more and exhaustive list of global in-vitro toxicology testing market companies contact, https://www.databridgemarketresearch.com/de/contact
Research Methodology: Global In-Vitro Toxicology Testing Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
